欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可持有人/公司名称	上市批准日期	授权状态
Vegzelma	Human	bevacizumab	bevacizumab	EMEA/H/C/005534	Celltrion Healthcare Hungary Kft.	2022/08/17	Authorised
Abevmy	Human	bevacizumab	bevacizumab	EMEA/H/C/005327	Biosimilar Collaborations Ireland Limited	2021/04/21	Authorised
Alymsys	Human	bevacizumab	bevacizumab	EMEA/H/C/005286	Mabxience Research SL	2021/03/26	Authorised
Oyavas	Human	bevacizumab	bevacizumab	EMEA/H/C/005556	STADA Arzneimittel AG	2021/03/26	Authorised
Onbevzi	Human	bevacizumab	bevacizumab	EMEA/H/C/005640	Samsung Bioepis NL B.V.	2021/01/11	Authorised
Equidacent	Human	bevacizumab	bevacizumab	EMEA/H/C/005181	Centus Biotherapeutics Europe Limited	2020/09/24	Withdrawn
Aybintio	Human	bevacizumab	bevacizumab	EMEA/H/C/005106	Samsung Bioepis NL B.V.	2020/08/19	Authorised
Zirabev	Human	bevacizumab	bevacizumab	EMEA/H/C/004697	Pfizer Europe MA EEIG	2019/02/14	Authorised
Mvasi	Human	bevacizumab	bevacizumab	EMEA/H/C/004728	Amgen Technology (Ireland) UC	2018/01/15	Authorised
Avastin	Human	bevacizumab	bevacizumab	EMEA/H/C/000582	Roche Registration GmbH	2005/01/12	Authorised
Ipique	Human	bevacizumab	bevacizumab	EMEA/H/C/005433	Rotterdam Biologics B.V.		Refused
Lextemy	Human	bevacizumab	bevacizumab	EMEA/H/C/005611	Mylan IRE Healthcare Limited		Withdrawn

药品名称Medicine name	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号Product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可持有人/公司名称Marketing authorisation holder/company name	*示例：Janssen
人用药物治疗分组Human pharmacotherapeutic group	*示例：Antineoplastic
适应症Condition / indication	*示例：leukaemia
授权状态Authorisation status
上市批准日期Marketing authorisation date	-